Allison Inserro

A real-world study of health care resource utilization (HCRU) in patients with myasthenia gravis on second-line therapy identified the factors that led to increased financial burdens.

Under the agreement, Takeda will pay Hutchmed $400 million up front and up to $730 million in additional potential payments relating to regulatory, development, and commercial sales milestones, as well as royalties on worldwide net sales, with the exception of mainland China, Hong Kong, and Macau.

Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.

The study sought to identify what factors were linked with developing depression in adults with asthma without a history of the disease, and to identify which factors were associated with recurrent depression during the pandemic in adults with both conditions.

Patients with higher health literacy and access to resources to self-advocate are more likely to benefit from health care consolidation, discussed Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.

The most common symptoms of long COVID include fatigue, anxiety and depression, shortness of breath, sleep disturbances, and heart palpitations.

Susan Sabo-Wagner MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, explained how cultural competency allows for better care delivery to patients with cancer.

The 10 drugs selected for Medicare Part D price negotiation with HHS will be announced on September 1, 2023, HHS said Wednesday.

Moving screening and prevention care more upstream can help make an impact by getting patients diagnosed with cancer earlier, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.

The diagnosis and treatment of a rare disease like spinal muscular atrophy (SMA) would benefit greatly from using implementation science to reduce the variation that exists in screening and therapy, according to researchers.

Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, spoke about the effects of isolation on patients with cancer who need help at home but have no one to provide it.

Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, discussed how housing conditions can impede positive outcomes for patients with cancer who are receiving cancer care support at home.

Biosimilars are a wonderful option for patients, but the growing number available can be challenging to manage when different payers prefer different agents, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.

Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, talked about the importance of having adequate support not only from clinical staff, but also emotional and moral support at home.

The dilemma of Alzheimer disease in primary care, as well as other health challenges in aging populations, was the focus of a recent Institute for Value-Based Medicine® event in Portland, Oregon.

The effects of the COVID-19 pandemic were clear in the US national health care expenditure analysis of spending last year, as federal spending dropped, but health care use rebounded in 2021.

Cough suppression therapy is a type of behavioral intervention, but like other behavioral interventions, it requires significant work on the part of the patient, meaning motivation, therapy attendance, and compliance with therapy techniques.

Coverage from the Institute for Value-Based Medicine® event with Oncology Consultants of Houston, held in Texas on October 11, 2022.

As they headed home Thursday from the 2022 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition in Las Vegas, pharmacists pitched in to help a man having a medical emergency aboard a United flight bound for Newark, New Jersey.

Sexually transmitted infections (STIs) are on the rise in the United States and have significant health and economic impacts, but pharmacists can help combat the spread as they work with affected patients.

A session at the 2022 American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition reviewed some trends in the 340B drug pricing programs and Medicaid.

A partnership between a university and the local Black community in San Bernadino County, California, illustrated how pharmacists can actively work to improve vaccine uptake in their communities.

Can a patient with metastatic cancer on immune checkpoint inhibitor (ICI) therapy use acetaminophen for pain? What about medical marijuana? And does the gut microbiome play a role? With more than a decade of real-world experience with ICIs, pharmacists learned about the potential role of these and other factors during a session at the 2022 American Society of Health-System Pharmacy Midyear Clinical Meeting & Exhibition.

A clinical pharmacy specialist with the Department of Veterans Affairs (VA) described how the department is trying to address the needs of female veterans, including their reproductive health, as well as addressing disparities in chronic diseases.

The increasing complexity and costs of oncology care and resulting patient financial toxicity is driving more health systems to adopt oncology stewardship principles in their pharmacy practices, according to a session at the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting & Exposition.

Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.

Optimized hemophilia care requires rapid, accurate, and high-quality genetic testing, but access to these tests varies across the European Union, according to a recent study.

The biologic is the first drug that aims to delay the diagnosis of type 1 diabetes.

Liability concerns cited by education administrators and nurses regarding the use of stock albuterol in school are overblown, according to researchers who examined how legislation about the issue has played out in Illinois.